Table 3.
Prevalence of dyslipidemia according to selected variables among patients with type 2 diabetes, Jordan, 2021 (N = 971).
| Variable | High total cholesterol*N (%) | High LDL*N (%) | High triglycerides*N (%) | Low HDL*N (%) |
|---|---|---|---|---|
| Duration of diabetes (years) | ||||
| >10 | 50 (13.2%) | 215 (49.9%) | 243 (56.4%) | 251 (64.6%) |
| ≤ 10 | 91 (23.3%) | 310 (63.8%) | 305 (62.5%) | 260 (64.7%) |
| P-value | 0.001 | 0.001 | 0.059 | 0.926 |
| HbA1c (%) | ||||
| ≤ 7 | 30 (13.5%) | 144 (54.8%) | 137 (52.5%) | 132 (56.9%) |
| 7.01–8 | 56 (21.1%) | 188 (57.8%) | 193 (59.4%) | 153 (55.4%) |
| >8 | 55 (19.6%) | 193 (58.7%) | 218 (65.5%) | 165 (58.1%) |
| P-value | 0.078 | 0.611 | 0.006 | 0.816 |
| Smoking | ||||
| Yes | 39 (19.2%) | 158 (62.2%) | 165 (65.2 %) | 136 (64.8%) |
| No | 102 (18.1%) | 367 (55.4%) | 383 (57.5%) | 375 (64.4%) |
| P-value | 0.715 | 0.061 | 0.033 | 0.932 |
| Age (years) | ||||
| < 50 | 31 (23.0%) | 122 (74.4%) | 98 (59.0%) | 95 (68.3%) |
| 50–60 | 63 (19.6%) | 222 (58.7%) | 226 (59.8%) | 213 (64.7%) |
| >60 | 47 (15.1%) | 181 (48.3%) | 224 (59.7%) | 203 (62.7%) |
| P-value | 0.105 | 0.001 | 0.985 | 0.500 |
| Gender | ||||
| Male | 54 (15.3%) | 219 (51.8%) | 269 (63.9%) | 228 (63.3%) |
| Female | 87 (20.9%) | 306 (61.9%) | 279 (56.0%) | 283 (65.5%) |
| P-value | 0.047 | 0.002 | 0.015 | 0.524 |
| BMI (kg/m 2 ) | ||||
| >25 | 10 (18.5%) | 38 (55.9%) | 26 (37.7%) | 26 (47.3%) |
| 25–29.9 | 46 (19.2%) | 165 (57.9%) | 164 (57.5%) | 137 (56.1%) |
| ≥30 | 85 (17.9%) | 322 (57.1%) | 358 (63.4%) | 348 (70.6) |
| P-value | 0.907 | 0.948 | 0.001 | 0.001 |
| Hypertension | ||||
| Yes | 83 (15.6%) | 330 (53.3%) | 394 (63.3%) | 371 (67.5%) |
| No | 58 (24.6%) | 195 (65.4%) | 154 (51.9%) | 140 (57.9%) |
| P-value | 0.003 | 0.001 | 0.001 | 0.009 |
| Lipid-lowering drugs | ||||
| No treatment | 25 (23.6%) | 109 (74.7%) | 67 (44.7%) | 53 (49.1%) |
| Statin only | 75 (16.3%) | 292 (54.0%) | 292 (54.1%) | 295 (62.1%) |
| Statin and fibrate only | 12 (21.4%) | 34 (56.7%) | 56 (93.3%) | 50 (86.2%) |
| Statin and omega | 15 (16.3%) | 52 (48.6%) | 83 (78.3%) | 67 (70.5%) |
| Fibrate only or fibrate and omega | 4 (40.0%) | 5 (45.5%) | 11 (100.0%) | 9 (81.8%) |
| Statin, fibrate, and omega | 8 (32.0%) | 15 (53.6%) | 24 (85.7%) | 22 (84.6%) |
| Omega only | 2 (11.1%) | 18 (75.0%) | 15 (62.5%) | 15 (78.9%) |
| P-value | 0.097 | 0.001 | 0.001 | 0.001 |
*
High total cholesterol (≥200) mg/dl, high LDL (Low Density Lipoprotein –cholesterol ≥ 100 mg/dl), high triglycerides (≥150) mg/dl, low HDL (High Density Lipoprotein–cholesterol: <40 mg/dl for males and <50 mg/dl for females).